Director of NLA Spoke about the Start of Clinical Trials of a Cure for Cancer

A well-known Kazakh-American biologist and General Director of the Astana National Laboratory (NLA) at NU, Dos Sarbassov, shared the latest news about the start of clinical trials of a cancer drug his team is working on. “Recently, we started clinical trials with the Kazakh Research Institute of Oncology and Radiology. It’s our first step in the clinic. Now the work of the first phase is underway – testing for toxicity and safety,” the professor shared. Dr Sarbassov also spoke about other NLA projects and the potential of Kazakh science. Read more in El.kz.